Activity

Filter

Cancel
Date Panel Item Activity
6 actions
Muscular dystrophy and myopathy_Paediatric v1.15 MMS19 Zornitza Stark Classified gene: MMS19 as Red List (low evidence)
Muscular dystrophy and myopathy_Paediatric v1.15 MMS19 Zornitza Stark Gene: mms19 has been classified as Red List (Low Evidence).
Muscular dystrophy and myopathy_Paediatric v1.14 MMS19 Zornitza Stark Marked gene: MMS19 as ready
Muscular dystrophy and myopathy_Paediatric v1.14 MMS19 Zornitza Stark Gene: mms19 has been removed from the panel.
Muscular dystrophy and myopathy_Paediatric v1.14 MMS19 Zornitza Stark Phenotypes for gene: MMS19 were changed from Neuromuscular disease, MMS19-related (MONDO:0019056) to Neurodegenerative disease, MONDO:0005559, MMS19-related
Muscular dystrophy and myopathy_Paediatric v1.13 MMS19 Paul De Fazio gene: MMS19 was added
gene: MMS19 was added to Muscular dystrophy and myopathy_Paediatric. Sources: Literature
Mode of inheritance for gene: MMS19 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: MMS19 were set to 38411040
Phenotypes for gene: MMS19 were set to Neuromuscular disease, MMS19-related (MONDO:0019056)
Review for gene: MMS19 was set to RED
gene: MMS19 was marked as current diagnostic
Added comment: Single patient reported with postnatal microcephaly, bilateral cataracts, failure to thrive, progressive spastic tetraparesis, scoliosis, myoclonic epilepsy and precocious puberty. Cerebral MRI at age 4 years showed pontocerebellar atrophy and white matter abnormalities. Patient died age 13 after recurrent respiratory tract infections. A homozygous in-frame deletion p.(Glu213del) was identified. Cell line studies supported pathogenicity of the variant. A zebrafish knockout model showed Mms19 deficiency had detrimental effects on development.
Sources: Literature